Literature DB >> 7543583

Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding.

N A Clarkson1, R Kaufman, D M Lublin, T Ward, P A Pipkin, P D Minor, D J Evans, J W Almond.   

Abstract

CD55, or decay-accelerating factor (DAF), is a cell surface glycoprotein which regulates complement activity by accelerating the decay of C3/C5 convertases. Recently, we and others have established that this molecule acts as a cellular receptor for echovirus 7 and related viruses. DAF consists of five domains: four short consensus repeats (SCRs) and a serine/threonine-rich region, attached to the cell surface by a glycosylphosphatidyl inositol anchor. Chinese hamster ovary cells stably transfected with deletion mutants of DAF or DAF-membrane cofactor protein recombinants were analyzed for virus binding. The results indicate that the binding of echovirus 7 to DAF specifically requires SCR2, SCR3, and SCR4. There is also a nonspecific requirement for the S/T-rich region which probably functions to project the binding region away from the cell membrane. The three nonpeptide modifications of DAF, N-linked glycosylation, O-linked glycosylation, and the glycosylphosphatidyl inositol anchor, are not required for virus binding. The SCRs of membrane cofactor protein, the closest known relative of DAF, cannot substitute for those of DAF with retention of virus binding activity. The monoclonal antibody used to identify DAF as an echovirus receptor, and which inhibits binding of the virus (monoclonal antibody 854), binds to SCR3.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543583      PMCID: PMC189399     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Identification of the integrin VLA-2 as a receptor for echovirus 1.

Authors:  J M Bergelson; M P Shepley; B M Chan; M E Hemler; R W Finberg
Journal:  Science       Date:  1992-03-27       Impact factor: 47.728

2.  Functional domains of the poliovirus receptor.

Authors:  S Koike; I Ise; A Nomoto
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

3.  Infection by echoviruses 1 and 8 depends on the alpha 2 subunit of human VLA-2.

Authors:  J M Bergelson; N St John; S Kawaguchi; M Chan; H Stubdal; J Modlin; R W Finberg
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

4.  Molecular cloning and expression of a murine homolog of the human poliovirus receptor gene.

Authors:  M E Morrison; V R Racaniello
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

5.  Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.

Authors:  J C Carel; B L Myones; B Frazier; V M Holers
Journal:  J Biol Chem       Date:  1990-07-25       Impact factor: 5.157

6.  The human CD46 molecule is a receptor for measles virus (Edmonston strain).

Authors:  R E Dörig; A Marcil; A Chopra; C D Richardson
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

7.  Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor.

Authors:  K E Coyne; S E Hall; S Thompson; M A Arce; T Kinoshita; T Fujita; D J Anstee; W Rosse; D M Lublin
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

8.  Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus.

Authors:  D Naniche; G Varior-Krishnan; F Cervoni; T F Wild; B Rossi; C Rabourdin-Combe; D Gerlier
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46).

Authors:  M Manchester; A Valsamakis; R Kaufman; M K Liszewski; J Alvarez; J P Atkinson; D M Lublin; M B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

10.  Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction.

Authors:  B Nowicki; A Hart; K E Coyne; D M Lublin; S Nowicki
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  34 in total

1.  Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.

Authors:  Amanda D Stuart; Thomas A McKee; Pamela A Williams; Chris Harley; Shuo Shen; David I Stuart; T David K Brown; Susan M Lea
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

2.  Localization of regions in CD46 that interact with adenovirus.

Authors:  Anuj Gaggar; Dmitry M Shayakhmetov; M Kathryn Liszewski; John P Atkinson; André Lieber
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  The distal short consensus repeats 1 and 2 of the membrane cofactor protein CD46 and their distance from the cell membrane determine productive entry of species B adenovirus serotype 35.

Authors:  Christoph Fleischli; Sandra Verhaagh; Menzo Havenga; Dominique Sirena; Walter Schaffner; Roberto Cattaneo; Urs F Greber; Silvio Hemmi
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Widespread balancing selection and pathogen-driven selection at blood group antigen genes.

Authors:  Matteo Fumagalli; Rachele Cagliani; Uberto Pozzoli; Stefania Riva; Giacomo P Comi; Giorgia Menozzi; Nereo Bresolin; Manuela Sironi
Journal:  Genome Res       Date:  2008-11-07       Impact factor: 9.043

5.  Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation.

Authors:  R M Powell; T Ward; D J Evans; J W Almond
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  A 3D model for the measles virus receptor CD46 based on homology modeling, Monte Carlo simulations, and hemagglutinin binding studies.

Authors:  C Mumenthaler; U Schneider; C J Buchholz; D Koller; W Braun; R Cattaneo
Journal:  Protein Sci       Date:  1997-03       Impact factor: 6.725

7.  The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48.

Authors:  R Malaviya; Z Gao; K Thankavel; P A van der Merwe; S N Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

8.  Role for beta2-microglobulin in echovirus infection of rhabdomyosarcoma cells.

Authors:  T Ward; R M Powell; P A Pipkin; D J Evans; P D Minor; J W Almond
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Human diffusely adhering Escherichia coli expressing Afa/Dr adhesins that use human CD55 (decay-accelerating factor) as a receptor does not bind the rodent and pig analogues of CD55.

Authors:  Sylvie Hudault; O Brad Spiller; B Paul Morgan; Alain L Servin
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  Enterovirus capsid interactions with decay-accelerating factor mediate lytic cell infection.

Authors:  Nicole G Newcombe; E Susanne Johansson; Gough Au; A Michael Lindberg; Richard D Barry; Darren R Shafren
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.